Clinical Trials Directory

Trials / Completed

CompletedNCT02756286

Neurophysiological Attention Test (NAT) for Objective Assessment of Adult ADHD

Status
Completed
Phase
Study type
Observational
Enrollment
258 (actual)
Sponsor
Think Now Incorporated · Industry
Sex
All
Age
18 Years – 40 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to refine a new assessment tool for Attention Deficit/Hyperactivity Disorder (ADHD) and then to test its validity (i.e. ability to discriminate between individuals with ADHD and healthy controls.

Detailed description

The purpose of this study is to build upon the success the novel approach and software for analyzing electroencephalography (EEG) data to identify biomarkers of ADHD in adults by further refining the method. Then to test the ability of this new assessment tool to differentiate between adults with ADHD and healthy controls by comparing the classification accuracy of the metrics from the new tool to the classification accuracy of existing behavioral tests for ADHD.

Conditions

Interventions

TypeNameDescription
OTHERNAT electroencephalography (EEG) testIndividuals in both groups are asked to perform standard behavioral tests and an electroencephalography (EEG) test.

Timeline

Start date
2017-01-01
Primary completion
2018-06-01
Completion
2018-07-05
First posted
2016-04-29
Last updated
2018-09-19

Locations

3 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT02756286. Inclusion in this directory is not an endorsement.